Back
Avalo Therapeutics Stock Price Chart
Sponsored
AVTX
Sponsored
The dark truth about AI
Click here to learn more...
Sell
31
AVTX
Avalo Therapeutics
Last Price:
9.30
Seasonality Move:
10.12%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AVTX is experiencing slight buying pressure.
Avalo Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.76 | Sell |
20-day SMA: | 10.12 | Sell |
50-day SMA: | 11.17 | Sell |
200-day SMA: | 10.89 | Sell |
8-day EMA: | 9.62 | Sell |
20-day EMA: | 10.22 | Sell |
50-day EMA: | 10.69 | Sell |
200-day EMA: | 37.33 | Sell |
Avalo Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.59 | Sell |
Relative Strength Index (14 RSI): | 36.43 | Sell |
Chaikin Money Flow: | 87044 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.33 - 12.11) | Sell |
Bollinger Bands (100): | (8.72 - 11.98) | Sell |
Avalo Therapeutics Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Avalo Therapeutics Stock
Is Avalo Therapeutics Stock a Buy?
- Avalo Therapeutics share price is 9.23 while AVTX 8-day simple moving average is 9.76, which is a Sell signal.
- The stock price of AVTX is 9.23 while Avalo Therapeutics 20-day SMA is 10.12, which makes it a Sell.
- Avalo Therapeutics 50-day simple moving average is 11.17 while AVTX share price is 9.23, making it a Sell technically.
- AVTX stock price is 9.23 and Avalo Therapeutics 200-day simple moving average is 10.89, creating a Sell signal.
AVTX Technical Analysis vs Fundamental Analysis
Sell
31
Avalo Therapeutics (AVTX)
is a Sell
Is Avalo Therapeutics a Buy or a Sell?
-
Avalo Therapeutics stock is rated a Sell
The current Avalo Therapeutics [AVTX] share price is $9.23. The Score for AVTX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Avalo Therapeutics Stock Info
Market Cap:
96.58M
Price in USD:
9.23
Share Volume:
189.1K
Avalo Therapeutics 52-Week Range
52-Week High:
34.46
52-Week Low:
3.95
Sell
31
Avalo Therapeutics (AVTX)
is a Sell
Avalo Therapeutics Share Price Forecast
-
What is the Avalo Therapeutics stock price today?
The Avalo Therapeutics stock price is 9.23 USD today. -
Will AVTX stock go up or go down?
Avalo Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Avalo Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Avalo Therapeutics is overvalued.
Is Avalo Therapeutics Stock a Buy?
- Avalo Therapeutics share price is 9.23 while AVTX 8-day exponential moving average is 9.62, which is a Sell signal.
- The stock price of AVTX is 9.23 while Avalo Therapeutics 20-day EMA is 10.22, which makes it a Sell.
- Avalo Therapeutics 50-day exponential moving average is 10.69 while AVTX share price is 9.23, making it a Sell technically.
- AVTX stock price is 9.23 and Avalo Therapeutics 200-day simple moving average is 37.33, creating a Sell signal.
Fundamental Analysis of Avalo Therapeutics
Is Avalo Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Avalo Therapeutics
Should I short Avalo Therapeutics stock?
- AVTX Moving Average Covergence Divergence (MACD) indicator is -0.59, suggesting Avalo Therapeutics is a Sell
- Avalo Therapeutics Relative Strength Index (RSI) is 36.43, which suggest Avalo Therapeutics is oversold
- The Bollinger Bands (25) for Avalo Therapeutics is (9.33 - 12.11), which suggest Avalo Therapeutics is a Sell
- The Bollinger Bands (100) for Avalo Therapeutics is (8.72 - 11.98), which suggest Avalo Therapeutics is a Sell
* Avalo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.